Amarin Corp Plcuk (AMRN) Receivables - Other (2010 - 2018)

Amarin Corp Plcuk (AMRN) posted quarterly Receivables - Other of $25.7 million for Q3 2018, up 7208.83% sequentially from $351000.0 in Q4 2010.

Amarin Corp Plcuk (AMRN) Receivables - Other (2010 - 2018) Analysis & Trends

Amarin Corp Plcuk has disclosed Receivables - Other across 2 years of filings, most recently posting $25.7 million for Q3 2018.

In Q3 2018, Receivables - Other changed N/A year-over-year to $25.7 million; the TTM figure through Sep 2018 stood at $25.7 million (changed N/A YoY), while the FY2010 annual figure was $351000.0, changed N/A from the prior year.
Receivables - Other rose to $25.7 million in Q3 2018, from $351000.0 in the prior quarter.
Over the last five years, Receivables - Other for AMRN reached as high as $25.7 million in Q3 2018 and fell as low as $25.7 million in Q3 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn
9	Novartis Ag	113.45 Bn	113.67 Bn	-
10	Amarin Corp Plcuk	5.17 Bn	5.00 Bn	17.77 Mn

Download Data